This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, W. Articles by Mayo, K. E. Search for Related Content PubMed PubMed Citation Articles by Chen, W. Articles by Mayo, K. E.

Activin A-Induced HepG2 Liver Cell Apoptosis: Involvement of Activin Receptors and Smad Proteins¹

Departments of Biochemistry, Molecular Biology, and Cell Biology (W.C., K.E.M.) and Neurobiology and Physiology (T.K.W., K.E.M.), Center for Reproductive Science, Northwestern University, Evanston, Illinois 60208

Address all correspondence and requests for reprints to: Dr. Kelly E. Mayo, Department of Biochemistry, Molecular Biology, and Cell Biology, 2153 North Campus Drive, Northwestern University, Evanston, Illinois 60208. E-mail: k-mayo{at}nwu.edu

A balance between cell proliferation and apoptosis is important for regulating normal liver function. Proteins of the transforming growth factor-ß superfamily are known to be important mediators of apoptosis in the liver. In this study we demonstrate that activin A potently induces apoptotic cell death in a hepatoma cell line, HepG2 cells. To determine the roles of activin receptors and downstream signaling proteins in activin A-induced apoptosis in these cells, the activin signaling pathway was analyzed using the transcription of an activin-responsive reporter gene, p3TP-Lux, as an assay. Although individual activin receptors had little effect on transcriptional activity, coexpression of an activin type I receptor and a type II receptor significantly increased both basal and activin-induced transcriptional activation, with the combination of receptors IB and IIB being the most potent. Similarly, expression of individual Smad proteins had only a modest effect on reporter gene activity, but the combination of Smad2 and Smad4 strongly stimulated transcription. Activin signaling induced a rapid relocation of Smad2 to the nucleus, as determined using a green fluorescence protein-Smad2 fusion protein. In contrast, green fluorescence protein-Smad4 remained localized to the cytoplasm unless it was coexpressed with Smad2. In agreement with the transcriptional response assays, overexpression or suppression of activin signaling components in HepG2 cells altered apoptosis. Overexpression of receptors IB and IIB or Smad proteins 2 and 4 stimulated apoptosis, whereas dominant negative mutant forms of the activin type IIB receptor or Smad2 blocked activin-stimulated apoptosis. These studies suggest that signaling from the cell surface to the nucleus through Smad proteins is a required component of the activin A-induced cell death process in liver cells.

This article has been cited by other articles:

				Y.-D. Wang, F. Yang, W.-D. Chen, X. Huang, L. Lai, B. M. Forman, and W. Huang Farnesoid X Receptor Protects Liver Cells from Apoptosis Induced by Serum Deprivation in Vitro and Fasting in Vivo Mol. Endocrinol., July 1, 2008; 22(7): 1622 - 1632. [Abstract] [Full Text] [PDF]

				A. Pellagatti, M. Jadersten, A.-M. Forsblom, H. Cattan, B. Christensson, E. K. Emanuelsson, M. Merup, L. Nilsson, J. Samuelsson, B. Sander, et al. Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients PNAS, July 3, 2007; 104(27): 11406 - 11411. [Abstract] [Full Text] [PDF]

				F. Debieve, L. Hinck, J.-M. Biard, P. Bernard, and C. Hubinont Activin receptor expression and induction of apoptosis in rat blastocysts in vitro Hum. Reprod., March 1, 2006; 21(3): 618 - 623. [Abstract] [Full Text] [PDF]

				S. K. Bristol-Gould, C. G. Hutten, C. Sturgis, S. M. Kilen, K. E. Mayo, and T. K. Woodruff The Development of a Mouse Model of Ovarian Endosalpingiosis Endocrinology, December 1, 2005; 146(12): 5228 - 5236. [Abstract] [Full Text] [PDF]

				E J Gold, X Zhang, A M Wheatley, S L Mellor, M Cranfield, G P Risbridger, N P Groome, and J S Fleming {beta}A- and {beta}C-activin, follistatin, activin receptor mRNA and {beta}C-activin peptide expression during rat liver regeneration J. Mol. Endocrinol., April 1, 2005; 34(2): 505 - 515. [Abstract] [Full Text] [PDF]

				A. Lacerte, E.-H. Lee, R. Reynaud, L. Canaff, C. de Guise, D. Devost, S. Ali, G. N. Hendy, and J.-J. Lebrun Activin Inhibits Pituitary Prolactin Expression and Cell Growth through Smads, Pit-1 and Menin Mol. Endocrinol., June 1, 2004; 18(6): 1558 - 1569. [Abstract] [Full Text] [PDF]

				J. L. Carey, L. M. Sasur, H. Kawakubo, V. Gupta, B. Christian, P. M. Bailey, and S. Maheswaran Mutually Antagonistic Effects of Androgen and Activin in the Regulation of Prostate Cancer Cell Growth Mol. Endocrinol., March 1, 2004; 18(3): 696 - 707. [Abstract] [Full Text] [PDF]

				C. W. Brown, L. Li, D. E. Houston-Hawkins, and M. M. Matzuk Activins Are Critical Modulators of Growth and Survival Mol. Endocrinol., December 1, 2003; 17(12): 2404 - 2417. [Abstract] [Full Text] [PDF]

				S. Vejda, N. Erlach, B. Peter, C. Drucker, W. Rossmanith, J. Pohl, R. Schulte-Hermann, and M. Grusch Expression of activins C and E induces apoptosis in human and rat hepatoma cells Carcinogenesis, November 1, 2003; 24(11): 1801 - 1809. [Abstract] [Full Text] [PDF]

				K. Hayashi, K. D. Carpenter, C. A. Gray, and T. E. Spencer The Activin-Follistatin System in the Neonatal Ovine Uterus Biol Reprod, September 1, 2003; 69(3): 843 - 850. [Abstract] [Full Text] [PDF]

				C. Tessier, A. Prigent-Tessier, L. Bao, C. M. Telleria, S. Ferguson-Gottschall, G. B. Gibori, Y. Gu, J. M. Bowen-Shauver, N. D. Horseman, and G. Gibori Decidual Activin: Its Role In the Apoptotic Process and Its Regulation by Prolactin Biol Reprod, May 1, 2003; 68(5): 1687 - 1694. [Abstract] [Full Text] [PDF]

				D. C. Danila, X. Zhang, Y. Zhou, J. N. S. Haidar, and A. Klibanski Overexpression of Wild-Type Activin Receptor Alk4-1 Restores Activin Antiproliferative Effects in Human Pituitary Tumor Cells J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4741 - 4746. [Abstract] [Full Text] [PDF]

				Y.-G. Chen, H. M. Lui, S.-L. Lin, J. M. Lee, and S.-Y. Ying Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis by Activin Experimental Biology and Medicine, February 1, 2002; 227(2): 75 - 87. [Abstract] [Full Text] [PDF]

				C. A. Bradham, E. Hatano, and D. A. Brenner Dominant-negative TAK1 induces c-Myc and G0 exit in liver Am J Physiol Gastrointest Liver Physiol, November 1, 2001; 281(5): G1279 - G1289. [Abstract] [Full Text] [PDF]

				Y. Mori, J. Yin, A. Rashid, B. A. Leggett, J. Young, L. Simms, P. M. Kuehl, P. Langenberg, S. J. Meltzer, and O. C. Stine Instabilotyping: Comprehensive Identification of Frameshift Mutations Caused by Coding Region Microsatellite Instability Cancer Res., August 1, 2001; 61(16): 6046 - 6049. [Abstract] [Full Text] [PDF]

				K.-C. Choi, S. K. Kang, C.-J. Tai, N. Auersperg, and P. C. K. Leung The Regulation of Apoptosis by Activin and Transforming Growth Factor-{beta} in Early Neoplastic and Tumorigenic Ovarian Surface Epithelium J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2125 - 2135. [Abstract] [Full Text]

				G. H. Su, R. Bansal, K. M. Murphy, E. Montgomery, C. J. Yeo, R. H. Hruban, and S. E. Kern ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma PNAS, March 13, 2001; 98(6): 3254 - 3257. [Abstract] [Full Text] [PDF]

				A. L. Lau, T. R. Kumar, K. Nishimori, J. Bonadio, and M. M. Matzuk Activin beta C and beta E Genes Are Not Essential for Mouse Liver Growth, Differentiation, and Regeneration Mol. Cell. Biol., August 15, 2000; 20(16): 6127 - 6137. [Abstract] [Full Text]